Postoperative Radiation Therapy Should Be Used for Completely Resected Stage III-N2 NSCLC in Select Patients

被引:17
作者
Liu, Jason [1 ]
Ladbury, Colton [1 ]
Kim, Jae [2 ]
Raz, Dan [2 ]
Erhunmwunsee, Loretta [2 ]
Jack West, Howard [3 ]
Williams, Terence [1 ]
Salgia, Ravi [3 ]
Massarelli, Erminia [3 ]
Amini, Arya [1 ]
机构
[1] City Hope Natl Med Ctr, Dept Radiat Oncol, 1500 E Duarte Rd, Duarte, CA 91010 USA
[2] City Hope Natl Med Ctr, Dept Thorac Surg, 1500 E Duarte Rd, Duarte, CA 91010 USA
[3] City Hope Natl Med Ctr, Dept Med Oncol, 1500 E Duarte Rd, Duarte, CA 91010 USA
关键词
Extensive mediastinal; CELL LUNG-CANCER;
D O I
10.1016/j.jtho.2021.08.006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:194 / 196
页数:3
相关论文
共 10 条
[1]   The Role of Consolidation Therapy for Stage III Non-Small Cell Lung Cancer With Persistent N2 Disease After Induction Chemotherapy [J].
Amini, Arya ;
Correa, Arlene M. ;
Komaki, Ritsuko ;
Chang, Joe Y. ;
Tsao, Anne S. ;
Roth, Jack A. ;
Swisher, Stephen G. ;
Rice, David C. ;
Vaporciyan, Ara A. ;
Lin, Steven H. .
ANNALS OF THORACIC SURGERY, 2012, 94 (03) :914-921
[2]   Mediastinal lymph node clearance after docetaxel-cisplatin Neoadjuvant chemotherapy is prognostic of survival in patients with stage IIIA pN2 non-small-cell lung cancer:: A multicenter phase II trial [J].
Betticher, DC ;
Schmitz, SFH ;
Tötsch, M ;
Hansen, E ;
Joss, C ;
von Briel, C ;
Schmid, RA ;
Pless, M ;
Habicht, J ;
Roth, AD ;
Spiliopoulos, A ;
Stahel, R ;
Weder, W ;
Stupp, R ;
Egli, F ;
Furrer, M ;
Honegger, H ;
Wernli, M ;
Cerny, T ;
Ris, HB .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (09) :1752-1759
[3]   Long-Term Results of NRG Oncology RTOG 0617: Standard- Versus High-Dose Chemoradiotherapy With or Without Cetuximab for Unresectable Stage III Non-Small-Cell Lung Cancer [J].
Bradley, Jeffrey D. ;
Hu, Chen ;
Komaki, Ritsuko R. ;
Masters, Gregory A. ;
Blumenschein, George R. ;
Schild, Steven E. ;
Bogart, Jeffrey A. ;
Forster, Kenneth M. ;
Magliocco, Anthony M. ;
Kavadi, Vivek S. ;
Narayan, Samir ;
Iyengar, Puneeth ;
Robinson, Clifford G. ;
Wynn, Raymond B. ;
Koprowski, Christopher D. ;
Olson, Michael R. ;
Meng, Joanne ;
Paulus, Rebecca ;
Curran, Walter J., Jr. ;
Choy, Hak .
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (07) :706-+
[4]   Postoperative radiotherapy for non-small cell lung cancer [J].
Burdett, Sarah ;
Rydzewska, Larysa ;
Tierney, Jayne ;
Fisher, David ;
Parmar, Mahesh K. B. ;
Arriagada, Rodrigo ;
Pignon, Jean Pierre ;
Le Pechoux, Cecile .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2016, (10)
[5]   Effect of Postoperative Radiotherapy for Patients With pIIIA-N2 Non-Small Cell Lung Cancer After Complete Resection and Adjuvant Chemotherapy The Phase 3 PORT-C Randomized Clinical Trial [J].
Hui, Zhouguang ;
Men, Yu ;
Hu, Chen ;
Kang, Jingjing ;
Sun, Xin ;
Bi, Nan ;
Zhou, Zongmei ;
Liang, Jun ;
Lv, Jima ;
Feng, Qinfu ;
Xiao, Zefen ;
Chen, Dongfu ;
Wang, Yan ;
Li, Junling ;
Wang, Jie ;
Gao, Shugeng ;
Wang, Luhua ;
He, Jie .
JAMA ONCOLOGY, 2021, 7 (08) :1178-1185
[6]   An international randomized trial, comparing post-operative conformal radiotherapy (PORT) to no PORT, in patients with completely resected non-small cell lung cancer (NSCLC) and mediastinal N2 involvement: Primary end-point analysis of LungART (IFCT-0503, UK NCRI, SAKK) NCT00410683 [J].
Le Pechoux, C. ;
Pourel, N. ;
Barlesi, F. ;
Faivre-Finn, C. ;
Lerouge, D. ;
Zalcman, G. ;
Antoni, D. ;
Lamezec, B. ;
Nestle, U. ;
Boisselier, P. ;
Thillays, F. ;
Paumier, A. ;
Dansin, E. ;
Peignaux, K. ;
Madelaine, J. ;
Pichon, E. ;
Larrouy, A. ;
Riesterer, O. ;
Lavole, A. ;
Bardet, A. .
ANNALS OF ONCOLOGY, 2020, 31 :S1178-S1178
[7]  
Matsuguma Haruhisa, 2008, Interact Cardiovasc Thorac Surg, V7, P573, DOI 10.1510/icvts.2007.174342
[8]   Prognostic Factors for Resected Non-Small Cell Lung Cancer with pN2 Status: Implications for Use of Postoperative Radiotherapy [J].
Moretti, Luigi ;
Yu, David S. ;
Chen, Heidi ;
Carbone, David P. ;
Johnson, David H. ;
Keedy, Vicki L. ;
Putnam, Joe B., Jr. ;
Sandler, Alan B. ;
Shyr, Yu ;
Lu, Bo .
ONCOLOGIST, 2009, 14 (11) :1106-1115
[9]   Effectiveness of postoperative irradiation in stage IIIA non-small cell lung cancer according to regression tree analyses of recurrence risks [J].
Sawyer, TE ;
Bonner, JA ;
Gould, PM ;
Foote, RL ;
Deschamps, C ;
Trastek, VF ;
Pairolero, PC ;
Allen, MS ;
Lange, CM ;
Li, HZ .
ANNALS OF THORACIC SURGERY, 1997, 64 (05) :1402-1407
[10]   Osimertinib in Resected EGFR-Mutated Non-Small-Cell Lung Cancer [J].
Wu, Yi-Long ;
Tsuboi, Masahiro ;
He, Jie ;
John, Thomas ;
Grohe, Christian ;
Majem, Margarita ;
Goldman, Jonathan W. ;
Laktionov, Konstantin ;
Kim, Sang-We ;
Kato, Terufumi ;
Vu, Huu-Vinh ;
Lu, Shun ;
Lee, Kye-Young ;
Akewanlop, Charuwan ;
Yu, Chong-Jen ;
de Marinis, Filippo ;
Bonanno, Laura ;
Domine, Manuel ;
Shepherd, Frances A. ;
Zeng, Lingmin ;
Hodge, Rachel ;
Atasoy, Ajlan ;
Rukazenkov, Yuri ;
Herbst, Roy S. .
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (18) :1711-1723